Liquid Lipids Act as Polymorphic Modifiers of Tristearin-Based Formulations Produced by Melting Technologies
Open Access
- 16 July 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (7) , 1089
Abstract
Despite the growing interest in lipid-based formulations, their polymorphism is still a challenge in the pharmaceutical industry. Understanding and controlling the polymorphic behavior of lipids is a key element for achieving the quality and preventing stability issues. This study aims to evaluate the impact of different oral-approved liquid lipids (LL) on the polymorphism, phase transitions and structure of solid lipid-based formulations and explore their influence on drug release. The LL investigated were isopropyl myristate, ethyl oleate, oleic acid, medium chain trigycerides, vitamin E acetate, glyceryl monooleate, lecithin and sorbitane monooleate. Spray-congealing was selected as an example of a melting-based solvent-free manufacturing method to produce microparticles (MPs) of tristearin (Dynasan®118). During the production process, tristearin MPs crystallized in the metastable α-form. Stability studied evidenced a slow phase transition to the stable β-polymorph overtime, with the presence of the α-form still detected after 60 days of storage at 25 °C. The addition of 10% w/w of LL promoted the transition of tristearin from the α-form to the stable β-form with a kinetic varying from few minutes to days, depending on the specific LL. The combination of various techniques (DSC, X-ray diffraction analysis, Hot-stage polarized light microscopy, SEM) showed that the addition of LL significantly modified the crystal structure of tristearin-based formulations at different length scales. Both the polymorphic form and the LL addition had a strong influence on the release behavior of a model hydrophilic drug (caffeine). Overall, the addition of LL can be considered an interesting approach to control triglyceride crystallization in the β-form. From the industrial viewpoint, this approach might be advantageous as any polymorphic change will be complete before storage, hence enabling the production of stable lipid formulations.Keywords
This publication has 61 references indexed in Scilit:
- Endocytic Uptake of Solid Lipid Nanoparticles by the Nasal MucosaPharmaceutics, 2021
- Enhanced Anticancer Efficacy of Dual Drug-Loaded Self-Assembled Nanostructured Lipid Carriers Mediated by pH-Responsive Folic Acid and Human-Derived Cell Penetrating Peptide dNP2Pharmaceutics, 2021
- Advanced stable lipid-based formulations for a patient-centric product designInternational Journal of Pharmaceutics, 2016
- Solvent-Free Melting Techniques for the Preparation of Lipid-Based Solid Oral FormulationsPharmaceutical Research, 2015
- Exploring the possible relationship between the drug release of Compritol®-containing tablets and its polymorph forms using micro X-ray diffractionJournal of Controlled Release, 2015
- Hot-melt coating with lipid excipientsInternational Journal of Pharmaceutics, 2013
- New trends in encapsulation of liposoluble vitaminsJournal of Controlled Release, 2010
- Impact of Surfactant Properties on Oxidative Stability of β-Carotene Encapsulated within Solid Lipid NanoparticlesJournal of Agricultural and Food Chemistry, 2009
- Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)—effect of surfactants, storage time and crystallinityInternational Journal of Pharmaceutics, 2002
- The Polymorphism of Glycerides.Chemical Reviews, 1962